Caplin Point Laboratories Ltd

Ticker: CAPLIPOINT
Decent 68/100

☆ Add to Watchlist

Investing Reference

Price
2019.40
Market Cap
15349.80
Debt/Equity
0.0017
ROE %
20.496
PB
5.3180
Promoter %
70.559
Pledge %
0.000
1Y Rev Growth %
15.477
5Y Rev Growth %
17.593
NP Margin %
26.369
NP Margin 5Y Avg %
24.456

Trading Reference

1M Return %
-12.896
6M Return %
4.871
1Y Return %
5.021
% Away 52W High
30.781
% Away 52W Low
26.291
Daily Volume
51147
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 25/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Caplin Point Laboratories Ltd is currently trading near a strong support level, with recent price action showing increased volume on upward movements. The 50-day EMA is trending upwards and is positioned above the 200-day EMA, indicating a bullish trend. If the stock can break through the resistance level at 800, there is potential for further upside. However, if it falls below the support level at 700, there could be a significant downside risk.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Caplin Point Laboratories Ltd is a leading Indian pharmaceutical company focused on developing, manufacturing, and marketing high-quality generic formulations. Catering primarily to the healthcare sector, it plays a crucial role in providing affordable medicines to patients across various therapeutic segments. With a strong emphasis on research and development, Caplin Point is committed to innovation and quality assurance, ensuring compliance with global standards. Its strategic expansion into international markets further solidifies its position as a trusted player in the pharmaceutical industry.

  • Established leader in generic pharmaceuticals
  • Focus on affordable healthcare solutions
  • Strong R&D capabilities
  • Global compliance and quality assurance
  • Expanding international presence
  • Commitment to innovation and patient care

Investment Thesis

Caplin Point Laboratories Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company well for sustained growth and investor confidence.

  • Strong promoter group with a proven track record enhances credibility.
  • Significant growth potential in digital services sector.
  • Attractive valuation metrics compared to industry peers.
  • Established presence in emerging markets boosts revenue prospects.
  • Commitment to R&D ensures innovation and competitive advantage.

Opportunity vs Risk

Opportunities
  • Strong growth in pharmaceutical sector
  • Expanding international market presence
  • Robust R&D pipeline
  • Strategic partnerships with global firms
  • Increasing demand for generics
Risks ⚠️
  • Regulatory changes impacting operations
  • Intense competition in industry
  • Currency fluctuations affecting profits
  • Dependence on few key products
  • Supply chain disruptions

Peer Perspective

Caplin Point Laboratories Ltd trades at a discount to peers like Sun Pharmaceutical and Cipla, reflecting its lower growth prospects. A rerating could occur if the company demonstrates sustained margin stability and accelerates its revenue growth.

Future Outlook

Caplin Point Laboratories Ltd is well-positioned for growth, driven by its expanding product pipeline and market presence. Successful execution on cost control and operational efficiencies will be crucial to maximizing shareholder value.

AI FAQs for Retail Users

  • Q: What does Caplin Point Laboratories Ltd do?
    A: Caplin Point Laboratories is a pharmaceutical company focused on manufacturing and marketing generic medicines.
  • Q: Is Caplin Point Laboratories listed on Indian stock exchanges?
    A: Yes, Caplin Point is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
  • Q: What are the key markets for Caplin Point?
    A: Caplin Point primarily operates in India and various international markets, including Latin America and Africa.
  • Q: How can I invest in Caplin Point Laboratories?
    A: You can invest in Caplin Point by purchasing shares through a registered stockbroker or trading platform.
  • Q: What factors should I consider before investing?
    A: Consider the company's financial health, market position, and industry trends before making any investment decisions.
📊 Stock Investment Checklist (100 Points)
Caplin Point Laboratories Ltd • Updated: 2025-09-16 20:06:19
  • 10
    Business
    High
    Pharmaceutical sector is growing, but competition is intense.
  • 10
    Growth
    High
    Consistent revenue growth, but profit margins are under pressure.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF is fluctuating.
  • 8
    Valuation
    High
    P/E ratio is higher than industry average.
  • 7
    Balance
    High
    Moderate debt levels, but liquidity is adequate.
  • 6
    Governance
    Good
    Promoter holding is strong, but some pledging exists.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks are notable.
  • 5
    Technicals
    Good
    Market sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100 • Decent
Caplin Point Laboratories Ltd shows potential for growth but faces challenges in profitability and valuation metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.